X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome
diseaseOn this page
Also known as intellectual developmental disorder, X-linked syndromic 32, X-linked recessiveintellectual disability, X-linked, syndromic 32intellectual disability, X-linked, syndromic type 32mental retardation, X-linked, syndromic 32mental retardation, X-linked, syndromic type 32MRXS32
Summary
X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome (MONDO:0010473) is a disease with 1 cohort gene.
At a glance
- Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
- Cohort genes: 1
- ClinVar variants: 6
- Phenotypes (HPO): 30
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Cases/families | 2 | Worldwide | Validated | |
| Point prevalence | <1 / 1 000 000 | Worldwide | Validated |
Signs & symptoms
Clinical features (HPO)
30 HPO clinical features (Orphanet curated; top 30 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0000396 | Overfolded helix | Frequent (30-79%) |
| HP:0000400 | Macrotia | Frequent (30-79%) |
| HP:0001172 | Abnormal thumb morphology | Frequent (30-79%) |
| HP:0001250 | Seizure | Frequent (30-79%) |
| HP:0001263 | Global developmental delay | Frequent (30-79%) |
| HP:0001344 | Absent speech | Frequent (30-79%) |
| HP:0001635 | Congestive heart failure | Frequent (30-79%) |
| HP:0001640 | Cardiomegaly | Frequent (30-79%) |
| HP:0002187 | Intellectual disability, profound | Frequent (30-79%) |
| HP:0005781 | Contractures of the large joints | Frequent (30-79%) |
| HP:0006705 | Abnormal atrioventricular valve morphology | Frequent (30-79%) |
| HP:0000053 | Macroorchidism | Occasional (5-29%) |
| HP:0000232 | Everted lower lip vermilion | Occasional (5-29%) |
| HP:0000280 | Coarse facial features | Occasional (5-29%) |
| HP:0000303 | Mandibular prognathia | Occasional (5-29%) |
| HP:0000319 | Smooth philtrum | Occasional (5-29%) |
| HP:0000414 | Bulbous nose | Occasional (5-29%) |
| HP:0000426 | Prominent nasal bridge | Occasional (5-29%) |
| HP:0001634 | Mitral valve prolapse | Occasional (5-29%) |
| HP:0001650 | Aortic valve stenosis | Occasional (5-29%) |
| HP:0001653 | Mitral regurgitation | Occasional (5-29%) |
| HP:0002465 | Poor speech | Occasional (5-29%) |
| HP:0002510 | Spastic tetraplegia | Occasional (5-29%) |
| HP:0002540 | Inability to walk | Occasional (5-29%) |
| HP:0002751 | Kyphoscoliosis | Occasional (5-29%) |
| HP:0003376 | Steppage gait | Occasional (5-29%) |
| HP:0004749 | Atrial flutter | Occasional (5-29%) |
| HP:0005180 | Tricuspid regurgitation | Occasional (5-29%) |
| HP:0005280 | Depressed nasal bridge | Occasional (5-29%) |
| HP:0010808 | Protruding tongue | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome |
| Mondo ID | MONDO:0010473 |
| OMIM | 300886 |
| Orphanet | 324410 |
| DOID | DOID:0060828 |
| UMLS | C3550913 |
| MedGen | 763827 |
| GARD | 0017485 |
| Is cancer (heuristic) | no |
Also known as: intellectual developmental disorder, X-linked syndromic 32, X-linked recessive · intellectual disability, X-linked, syndromic 32 · intellectual disability, X-linked, syndromic type 32 · mental retardation, X-linked, syndromic 32 · mental retardation, X-linked, syndromic type 32 · MRXS32
Data availability: 6 ClinVar variants · 5 GenCC gene-disease records.
Disease family
Classification path: disease › human disease › disease by body system or component › nervous system disorder › neurodevelopmental disorder › intellectual disability › syndromic intellectual disability › X-linked syndromic intellectual disability › X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome
Related subtypes (80): X-linked intellectual disability-psychosis-macroorchidism syndrome, X-linked intellectual disability-plagiocephaly syndrome, intellectual disability, X-linked 49, MEHMO syndrome, syndromic X-linked intellectual disability 7, syndromic X-linked intellectual disability Shashi type, syndromic X-linked intellectual disability Lubs type, syndromic X-linked intellectual disability Abidi type, syndromic X-linked intellectual disability Siderius type, X-linked intellectual disability, Cabezas type, X-linked intellectual disability, Stocco dos Santos type, X-linked intellectual disability-cubitus valgus-dysmorphism syndrome, corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome, X-linked intellectual disability-cerebellar hypoplasia syndrome, Allan-Herndon-Dudley syndrome, syndromic X-linked intellectual disability Claes-Jensen type, X-linked intellectual disability-retinitis pigmentosa syndrome, syndromic X-linked intellectual disability 14, syndromic X-linked intellectual disability 94, intellectual disability, X-linked syndromic, Turner type, syndromic X-linked intellectual disability Shrimpton type, X-linked intellectual disability-craniofacioskeletal syndrome, syndromic X-linked intellectual disability Raymond type, syndromic X-linked intellectual disability 17, syndromic X-linked intellectual disability Nascimento type, syndromic X-linked intellectual disability Chudley-Schwartz type, X-linked intellectual disability, Cantagrel type, X-linked intellectual disability-short stature-overweight syndrome, intellectual disability, X-linked, syndromic 33, syndromic X-linked intellectual disability 34, intellectual disability, X-linked 99, syndromic, female-restricted, intellectual disability, X-linked, syndromic, Bain type, Borjeson-Forssman-Lehmann syndrome, Coffin-Lowry syndrome, syndromic X-linked intellectual disability 5, X-linked intellectual disability-seizures-psoriasis syndrome, Renpenning syndrome, Partington syndrome, syndromic X-linked intellectual disability 12, severe X-linked intellectual disability, Gustavson type, syndromic X-linked intellectual disability Snyder type, Wilson-Turner syndrome, Prieto syndrome, skeletal dysplasia-intellectual disability syndrome, X-linked intellectual disability-spastic quadriparesis syndrome, early-onset parkinsonism-intellectual disability syndrome, X-linked intellectual disability, Schimke type, X-linked intellectual disability, Cilliers type, X-linked intellectual disability, van Esch type, X-linked intellectual disability-epilepsy syndrome, ATR-X-related syndrome, X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome, X-linked intellectual disability, Schutz type, X-linked intellectual disability-hypotonia-movement disorder syndrome, X-linked intellectual disability with isolated growth hormone deficiency, X-linked intellectual disability-hypogammaglobulinemia-progressive neurological deterioration syndrome, X-linked intellectual disability-precocious puberty-obesity syndrome, X-linked intellectual disability-epilepsy-progressive joint contractures-dysmorphism syndrome, X-linked intellectual disability-macrocephaly-macroorchidism syndrome, X-linked intellectual disability, Pai type, X-linked intellectual disability, Seemanova type, X-linked intellectual disability, Stevenson type, X-linked intellectual disability, Stoll type, X-linked intellectual disability-acromegaly-hyperactivity syndrome, X-linked intellectual disability-corpus callosum agenesis-spastic quadriparesis syndrome, fried syndrome, X-linked intellectual disability-ataxia-apraxia syndrome, intellectual developmental disorder, X-linked, syndromic, Pilorge type, Paganini-Miozzo syndrome, intellectual developmental disorder, X-linked, syndromic, Hackmann-Di Donato type, intellectual disability, X-linked, syndromic, 35, intellectual disability, X-linked, syndromic, Houge type, MED12-related intellectual disability syndrome, NAA10-related syndrome, ATP6AP2-related disorder, X-linked intellectual disability with hypopituitarism, SOX3-related X-linked pituitary hormone deficiency with or without intellectual developmental disorder, intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies, intellectual developmental disorder, X-linked, syndromic 37, CASK-related intellectual disability
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
ClinVar germline variants
6 retrieved; paginated sample, class counts are floors:
4 uncertain significance, 1 likely benign, 1 conflicting classifications of pathogenicity
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 1675174 | NM_001289.6(CLIC2):c.19G>A (p.Gly7Ser) | CLIC2 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications |
| 1029305 | NM_001289.6(CLIC2):c.103C>T (p.Arg35Cys) | CLIC2 | Uncertain significance | criteria provided, single submitter |
| 1334434 | NM_001289.6(CLIC2):c.392C>A (p.Ala131Glu) | CLIC2 | Uncertain significance | no assertion criteria provided |
| 3064497 | NM_001289.6(CLIC2):c.171G>C (p.Lys57Asn) | CLIC2 | Uncertain significance | criteria provided, single submitter |
| 39823 | NM_001289.6(CLIC2):c.303C>G (p.His101Gln) | CLIC2 | Uncertain significance | criteria provided, single submitter |
| 1321269 | NM_001289.6(CLIC2):c.434G>A (p.Arg145His) | CLIC2 | Likely benign | criteria provided, single submitter |
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 6 · Orphanet: 1 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
GenCC gene–disease validity (cohort genes)
the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.
| Gene | Classification | Inheritance | Disease | Records |
|---|---|---|---|---|
| CLIC2 | Moderate | X-linked | X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome | 6 |
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| CLIC2 | Orphanet:324410 | X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome |
Cohort genes → proteins
1 cohort genes, 1 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 1 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| CLIC2 | HGNC:2063 | ENSG00000155962 | O15247 | Chloride intracellular channel protein 2 | gencc,clinvar |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| CLIC2 | Chloride intracellular channel protein 2 | In the soluble state, catalyzes glutaredoxin-like thiol disulfide exchange reactions with reduced glutathione as electron donor. |
Protein-family classification
Druggable: 0 · Difficult: 0 · Unknown: 1 · Druggable fraction: 0.0
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Other/Unknown | 1 | 1.8× | 0.558 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| CLIC2 | Other/Unknown | no | CLIC, Glutathione-S-Trfase_C-like, GST_C_CLIC-2 |
Expression context
Cohort genes with no expression data: 0.
1 cohort gene are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 0 |
| broad (>20) | 1 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| calcaneal tendon | 1 |
| colonic epithelium | 1 |
| right lung | 1 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| CLIC2 | 232 | broad | marker | calcaneal tendon, colonic epithelium, right lung |
Protein interactions among cohort
Intra-cohort edges: 0.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| CLIC2 | 922 |
Structural data
PDB: 1 · AlphaFold-only: 0 · No structure: 0
Cohort genes with PDB structures (top 30)
| Symbol | UniProt | PDB entries |
|---|---|---|
| CLIC2 | O15247 | 3 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 2. Enrichment computed across 1 evidence-associated genes (1 with Reactome annotation).
Pathways by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| Pathway | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| Ion homeostasis | 1 | 203.9× | 0.007 | CLIC2 |
| Stimuli-sensing channels | 1 | 135.9× | 0.007 | CLIC2 |
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1 | 674.1× | 0.003 | CLIC2 |
| regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 1 | 674.1× | 0.003 | CLIC2 |
| chloride transport | 1 | 455.5× | 0.003 | CLIC2 |
| signal transduction | 1 | 16.1× | 0.062 | CLIC2 |
Therapeutics
Drug target analysis
Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 1
Druggability breadth: 0 of 1 evidence-associated genes (0%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| CLIC2 | 0 | 0 |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 0.
Pharmacogenomics
Cohort genes with a PharmGKB record: 1; with CPIC/DPWG dosing guidelines: 0.
No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).
Chemical tractability of cohort targets
0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 0 | |
| B | Phased (≥1) drug, not yet approved | 0 | |
| C | Druggable family + PDB, no drug | 0 | |
| D | Druggable family + AlphaFold only, no drug | 0 | |
| E | Difficult family or no structure, no drug | 1 | CLIC2 |
Undrugged target profiles
1 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| CLIC2 | 0 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
- Cohort genes: CLIC2